Danaher (DHR) Competitors

$172.12 +0.12 (+0.07%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$172.24 +0.12 (+0.07%)

As of 05/22/2026 07:44 PM Eastern

DHR vs. RGEN, TECH, A, CR, and CSL

Should you buy Danaher stock or one of its competitors? MarketBeat compares Danaher with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Danaher include Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), Crane (CR), and Carlisle Companies (CSL).

How does Danaher compare to Repligen?

Danaher (NYSE:DHR) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

Danaher currently has a consensus price target of $238.65, indicating a potential upside of 38.65%. Repligen has a consensus price target of $166.15, indicating a potential upside of 44.41%. Given Repligen's stronger consensus rating and higher possible upside, analysts clearly believe Repligen is more favorable than Danaher.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Repligen	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.87

Danaher has higher revenue and earnings than Repligen. Danaher is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.57B	4.96	$3.61B	$5.17	33.29
Repligen	$738.26M	8.79	$48.89M	$0.90	127.84

Danaher has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Repligen has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market.

79.1% of Danaher shares are owned by institutional investors. Comparatively, 97.6% of Repligen shares are owned by institutional investors. 10.8% of Danaher shares are owned by company insiders. Comparatively, 0.6% of Repligen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Danaher had 21 more articles in the media than Repligen. MarketBeat recorded 27 mentions for Danaher and 6 mentions for Repligen. Danaher's average media sentiment score of 1.21 beat Repligen's score of 0.40 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	21 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Repligen	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Danaher has a net margin of 14.89% compared to Repligen's net margin of 6.73%. Danaher's return on equity of 10.91% beat Repligen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Repligen	6.73%	4.88%	3.48%

Summary

Danaher beats Repligen on 10 of the 17 factors compared between the two stocks.

How does Danaher compare to Bio-Techne?

Danaher (NYSE:DHR) and Bio-Techne (NASDAQ:TECH) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

Danaher has a net margin of 14.89% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Bio-Techne	9.05%	13.57%	10.66%

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.7%. Danaher pays out 30.9% of its earnings in the form of a dividend. Bio-Techne pays out 46.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has raised its dividend for 2 consecutive years. Danaher is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Danaher has higher revenue and earnings than Bio-Techne. Danaher is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.57B	4.96	$3.61B	$5.17	33.29
Bio-Techne	$1.22B	6.19	$73.40M	$0.69	69.87

Danaher has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

79.1% of Danaher shares are held by institutional investors. Comparatively, 99.0% of Bio-Techne shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Comparatively, 1.3% of Bio-Techne shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Danaher currently has a consensus target price of $238.65, suggesting a potential upside of 38.65%. Bio-Techne has a consensus target price of $65.92, suggesting a potential upside of 36.74%. Given Danaher's stronger consensus rating and higher probable upside, research analysts clearly believe Danaher is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Bio-Techne	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.79

In the previous week, Danaher had 23 more articles in the media than Bio-Techne. MarketBeat recorded 27 mentions for Danaher and 4 mentions for Bio-Techne. Danaher's average media sentiment score of 1.21 beat Bio-Techne's score of 0.00 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	21 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Techne	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Danaher beats Bio-Techne on 13 of the 20 factors compared between the two stocks.

How does Danaher compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Danaher (NYSE:DHR) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

Agilent Technologies has a net margin of 18.26% compared to Danaher's net margin of 14.89%. Agilent Technologies' return on equity of 24.49% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	18.26%	24.49%	12.83%
Danaher	14.89%	10.91%	6.94%

Agilent Technologies has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market. Comparatively, Danaher has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

79.1% of Danaher shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Agilent Technologies presently has a consensus price target of $163.71, indicating a potential upside of 42.35%. Danaher has a consensus price target of $238.65, indicating a potential upside of 38.65%. Given Agilent Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe Agilent Technologies is more favorable than Danaher.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Danaher	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

Danaher has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	4.68	$1.30B	$4.53	25.39
Danaher	$24.57B	4.96	$3.61B	$5.17	33.29

Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.9%. Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Agilent Technologies pays out 22.5% of its earnings in the form of a dividend. Danaher pays out 30.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies has increased its dividend for 9 consecutive years and Danaher has increased its dividend for 2 consecutive years.

In the previous week, Danaher had 7 more articles in the media than Agilent Technologies. MarketBeat recorded 27 mentions for Danaher and 20 mentions for Agilent Technologies. Danaher's average media sentiment score of 1.21 beat Agilent Technologies' score of 0.51 indicating that Danaher is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	7 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Danaher	21 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Danaher beats Agilent Technologies on 11 of the 20 factors compared between the two stocks.

How does Danaher compare to Crane?

Danaher (NYSE:DHR) and Crane (NYSE:CR) are related large-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

In the previous week, Danaher had 21 more articles in the media than Crane. MarketBeat recorded 27 mentions for Danaher and 6 mentions for Crane. Danaher's average media sentiment score of 1.21 beat Crane's score of 0.80 indicating that Danaher is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Danaher	21 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Crane	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Danaher has higher revenue and earnings than Crane. Crane is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Danaher	$24.57B	4.96	$3.61B	$5.17	33.29
Crane	$2.44B	4.25	$401.10M	$5.56	32.32

Danaher has a net margin of 14.89% compared to Crane's net margin of 13.10%. Crane's return on equity of 24.45% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Danaher	14.89%	10.91%	6.94%
Crane	13.10%	24.45%	10.14%

Danaher has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, Crane has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

Danaher presently has a consensus target price of $238.65, indicating a potential upside of 38.65%. Crane has a consensus target price of $226.33, indicating a potential upside of 25.94%. Given Danaher's higher possible upside, research analysts clearly believe Danaher is more favorable than Crane.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Danaher	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Crane	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.13

79.1% of Danaher shares are owned by institutional investors. Comparatively, 75.1% of Crane shares are owned by institutional investors. 10.8% of Danaher shares are owned by insiders. Comparatively, 2.1% of Crane shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Crane pays an annual dividend of $1.02 per share and has a dividend yield of 0.6%. Danaher pays out 30.9% of its earnings in the form of a dividend. Crane pays out 18.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Danaher has raised its dividend for 2 consecutive years and Crane has raised its dividend for 3 consecutive years.

Summary

Danaher beats Crane on 12 of the 20 factors compared between the two stocks.

How does Danaher compare to Carlisle Companies?

Carlisle Companies (NYSE:CSL) and Danaher (NYSE:DHR) are both large-cap industrial conglomerates companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings, media sentiment and risk.

Carlisle Companies currently has a consensus target price of $405.00, indicating a potential upside of 21.19%. Danaher has a consensus target price of $238.65, indicating a potential upside of 38.65%. Given Danaher's stronger consensus rating and higher possible upside, analysts clearly believe Danaher is more favorable than Carlisle Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlisle Companies	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45
Danaher	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

Danaher has a net margin of 14.89% compared to Carlisle Companies' net margin of 14.57%. Carlisle Companies' return on equity of 43.78% beat Danaher's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlisle Companies	14.57%	43.78%	13.66%
Danaher	14.89%	10.91%	6.94%

Danaher has higher revenue and earnings than Carlisle Companies. Carlisle Companies is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlisle Companies	$5.02B	2.69	$740.70M	$17.01	19.65
Danaher	$24.57B	4.96	$3.61B	$5.17	33.29

Carlisle Companies pays an annual dividend of $4.40 per share and has a dividend yield of 1.3%. Danaher pays an annual dividend of $1.60 per share and has a dividend yield of 0.9%. Carlisle Companies pays out 25.9% of its earnings in the form of a dividend. Danaher pays out 30.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Carlisle Companies has raised its dividend for 48 consecutive years and Danaher has raised its dividend for 2 consecutive years. Carlisle Companies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

89.5% of Carlisle Companies shares are owned by institutional investors. Comparatively, 79.1% of Danaher shares are owned by institutional investors. 1.3% of Carlisle Companies shares are owned by insiders. Comparatively, 10.8% of Danaher shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Carlisle Companies has a beta of 0.88, indicating that its share price is 12% less volatile than the broader market. Comparatively, Danaher has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

In the previous week, Danaher had 17 more articles in the media than Carlisle Companies. MarketBeat recorded 27 mentions for Danaher and 10 mentions for Carlisle Companies. Danaher's average media sentiment score of 1.21 beat Carlisle Companies' score of 0.59 indicating that Danaher is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Carlisle Companies	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Danaher	21 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Danaher beats Carlisle Companies on 11 of the 19 factors compared between the two stocks.

Get Danaher News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DHR vs. The Competition

Export

Metric	Danaher	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$121.74B	$8.38B	$6.46B	$23.20B
Dividend Yield	0.93%	2.98%	2.76%	4.10%
P/E Ratio	33.29	21.27	21.22	30.65
Price / Sales	4.96	19.11	562.28	24.50
Price / Cash	15.13	86.20	43.49	25.12
Price / Book	2.30	5.84	10.31	4.74
Net Income	$3.61B	$183.47M	$3.57B	$1.07B
7 Day Performance	3.09%	64.18%	6.43%	2.36%
1 Month Performance	-2.92%	49.96%	3.57%	1.58%
1 Year Performance	-6.85%	4.53%	34.07%	28.42%

Danaher Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DHR Danaher	4.7493 of 5 stars	$172.12 +0.1%	$238.65 +38.7%	-6.9%	$121.74B	$24.57B	33.29	60,000	Positive News
RGEN Repligen	3.6536 of 5 stars	$113.37 +1.5%	$166.15 +46.6%	-2.6%	$6.40B	$738.26M	125.97	2,000
TECH Bio-Techne	3.4467 of 5 stars	$47.37 +1.4%	$65.92 +39.2%	+3.1%	$7.42B	$1.22B	68.65	3,100
A Agilent Technologies	4.8777 of 5 stars	$114.77 +0.9%	$163.71 +42.7%	+5.9%	$32.43B	$6.95B	25.33	18,100	Upcoming Earnings Dividend Announcement
CR Crane	4.678 of 5 stars	$175.53 +1.2%	$226.33 +28.9%	+5.7%	$10.14B	$2.44B	23.25	11,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DHR) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Danaher (DHR) Competitors